Literature DB >> 19583682

Multiple drug interactions - induced serotonin syndrome: a case report.

E Montané1, A Barriocanal, I Isern, T Parajon, J Costa.   

Abstract

Serotonin syndrome is a potentially life-threatening disorder of excessive serotoninergic activity often due to drug interactions. We report a case of serotonin syndrome induced by pharmacokinetic and pharmacodynamic interactions between three different selective serotonin-reuptake inhibitors (SSRI) and possibly ciprofloxacin. Extreme caution is necessary in patients treated with serotonin-reuptake inhibitors who need to be switched to another antidepressant or when they require the addition of concomitant drugs, especially serotoninergic drugs and isoenzimes of cytochrome P450 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19583682     DOI: 10.1111/j.1365-2710.2009.01023.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

Review 1.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

2.  Drug interaction and pharmacist.

Authors:  Ja Ansari
Journal:  J Young Pharm       Date:  2010-07

3.  Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms.

Authors:  Julie Samyde; Pierre Petit; Dominique Hillaire-Buys; Jean-Luc Faillie
Journal:  Psychopharmacology (Berl)       Date:  2016-04-26       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.